PT1093380E - Componente b como agente angiogenico em combinacao com factores de crescimento humano - Google Patents
Componente b como agente angiogenico em combinacao com factores de crescimento humanoInfo
- Publication number
- PT1093380E PT1093380E PT99934563T PT99934563T PT1093380E PT 1093380 E PT1093380 E PT 1093380E PT 99934563 T PT99934563 T PT 99934563T PT 99934563 T PT99934563 T PT 99934563T PT 1093380 E PT1093380 E PT 1093380E
- Authority
- PT
- Portugal
- Prior art keywords
- combination
- human growth
- component
- growth factors
- angiogenic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98112775 | 1998-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1093380E true PT1093380E (pt) | 2003-01-31 |
Family
ID=8232248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99934563T PT1093380E (pt) | 1998-07-09 | 1999-07-02 | Componente b como agente angiogenico em combinacao com factores de crescimento humano |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6855684B2 (pt) |
| EP (1) | EP1093380B1 (pt) |
| JP (1) | JP2002520292A (pt) |
| AT (1) | ATE224200T1 (pt) |
| AU (1) | AU765600B2 (pt) |
| CA (1) | CA2336773C (pt) |
| DE (1) | DE69903037T2 (pt) |
| DK (1) | DK1093380T3 (pt) |
| ES (1) | ES2184480T3 (pt) |
| IL (2) | IL140778A0 (pt) |
| PT (1) | PT1093380E (pt) |
| WO (1) | WO2000002579A2 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE224200T1 (de) * | 1998-07-09 | 2002-10-15 | Applied Research Systems | Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren |
| AU2001291019A1 (en) | 2000-09-15 | 2002-03-26 | Genvec, Inc. | Method of modulating neovascularization |
| WO2004091646A2 (en) | 2003-04-16 | 2004-10-28 | Applied Research Systems Ars Holding, N.V. | Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| WO2006060803A2 (en) * | 2004-12-03 | 2006-06-08 | Polnox Corporation | One pot process for making polymeric antioxidants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1257184B (it) * | 1992-12-22 | 1996-01-10 | Applied Research Systems | Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale |
| US5998364A (en) * | 1996-04-24 | 1999-12-07 | Applied Research Systems Ars Holding N.V. | Component B as cicatrizant |
| ATE224200T1 (de) * | 1998-07-09 | 2002-10-15 | Applied Research Systems | Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren |
-
1999
- 1999-07-02 AT AT99934563T patent/ATE224200T1/de active
- 1999-07-02 JP JP2000558838A patent/JP2002520292A/ja active Pending
- 1999-07-02 PT PT99934563T patent/PT1093380E/pt unknown
- 1999-07-02 IL IL14077899A patent/IL140778A0/xx active IP Right Grant
- 1999-07-02 WO PCT/EP1999/004605 patent/WO2000002579A2/en active IP Right Grant
- 1999-07-02 DE DE69903037T patent/DE69903037T2/de not_active Expired - Lifetime
- 1999-07-02 AU AU50306/99A patent/AU765600B2/en not_active Ceased
- 1999-07-02 CA CA002336773A patent/CA2336773C/en not_active Expired - Fee Related
- 1999-07-02 EP EP99934563A patent/EP1093380B1/en not_active Expired - Lifetime
- 1999-07-02 ES ES99934563T patent/ES2184480T3/es not_active Expired - Lifetime
- 1999-07-02 DK DK99934563T patent/DK1093380T3/da active
-
2001
- 2001-01-08 IL IL140778A patent/IL140778A/en not_active IP Right Cessation
- 2001-01-09 US US09/756,185 patent/US6855684B2/en not_active Expired - Fee Related
-
2004
- 2004-12-10 US US11/008,175 patent/US7223732B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002520292A (ja) | 2002-07-09 |
| AU765600B2 (en) | 2003-09-25 |
| IL140778A (en) | 2008-03-20 |
| ES2184480T3 (es) | 2003-04-01 |
| US20050153892A1 (en) | 2005-07-14 |
| IL140778A0 (en) | 2002-02-10 |
| US7223732B2 (en) | 2007-05-29 |
| WO2000002579A3 (en) | 2000-02-24 |
| CA2336773A1 (en) | 2000-01-20 |
| CA2336773C (en) | 2009-12-15 |
| US6855684B2 (en) | 2005-02-15 |
| US20010031733A1 (en) | 2001-10-18 |
| WO2000002579A2 (en) | 2000-01-20 |
| DK1093380T3 (da) | 2003-01-27 |
| ATE224200T1 (de) | 2002-10-15 |
| AU5030699A (en) | 2000-02-01 |
| DE69903037D1 (de) | 2002-10-24 |
| EP1093380B1 (en) | 2002-09-18 |
| EP1093380A2 (en) | 2001-04-25 |
| DE69903037T2 (de) | 2003-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003123A1 (es) | Una composicion sinergica de por lo menos un compuesto de actividad antimicrobiana y de por lo menos un monoalquileter de glicerol y utilizacionesde los mismos como agentes antimicrobianos en una composicion cosmetica o farmaceutica como asi tambien en la preparacion de composiciones farmaceuticas | |
| TR200003635T2 (tr) | Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması. | |
| BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
| BR0003897A (pt) | Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos | |
| BR0008926A (pt) | Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano | |
| SE9701162D0 (sv) | New use II | |
| BR0115323A (pt) | Uso de cci-779 como agente antineoplástico | |
| BE2011C037I2 (pt) | ||
| DK1235571T3 (da) | Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type | |
| DE69922152D1 (de) | Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung | |
| DE69921318D1 (de) | Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate | |
| CY1104971T1 (el) | Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους | |
| IT1264530B (it) | Impiego dei polisaccaridi nelle neuropatie atrofico degenerative | |
| PT1093380E (pt) | Componente b como agente angiogenico em combinacao com factores de crescimento humano | |
| ES2178405T3 (es) | Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas. | |
| PT1076540E (pt) | Ligadura de compressao | |
| DE69905392T2 (de) | Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid | |
| BR9301375A (pt) | Composicao cosmetica | |
| ES2152664T3 (es) | Combinacion de cis-4-hidroxi-l-prolina y n-metil-cis-4-hidroxi-l-prolina para aplicacion como agente terapeutico, especialmente para el tratamiento contra el cancer. | |
| DE69808663D1 (de) | Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie | |
| SE8802257D0 (sv) | Antimikrobiell komposition | |
| PT1313500E (pt) | Associacoes de dalfopristina/quinupristina com o cefpirome | |
| IT1302920B1 (it) | Uso della propoli nel trattamento della vitiligine e della psoriasi. | |
| IT1305974B1 (it) | Composto di sostanze naturali con funzione di insetticida dautilizzarsi ai sensi della normativa europea n. 2092/91 del 24 giugno | |
| UA36485A (uk) | Спосіб лікування генералізованого пародонтиту |